Author: Dr. Ali Ahsan
About The Author
Dr. Ali Ahsan
Dr. Ali Ahsan holds a medical degree, MBBS, from Shaheed Zulfiqar Ali Bhutto Medical University, Pakistan. He is a medical doctor and he plans to pursue pathology in his residency. He has worked with a public health organization where he worked on various projects related to public health issues. He is interested in writing about health topics to create public awareness about medicine as a profession and prevalent health issues. He enjoys medical writing as it serves as a bridge for medical knowledge communication and spreading health awareness between the medical profession and the general public.
Music Practice Leads to Enhanced Cerebellar Grey Matter and Improved Auditory Working Memory in Older Adults
A recent study showed that music training involving active practice increases grey matter in the brain’s cerebellum and improves auditory working memory in healthy older adults. A team of …
Headaches: Types, Symptoms, Causes, and the Latest Insights from Medical Research
A Headache is one of the most common symptoms of a clinical presentation and it is one of the most common types of pain that people complain of. A …
AI in Healthcare: The AMA’s Plan to Tackle Misinformation and Patient Safety
AI in healthcare Applications of Artificial intelligence in healthcare have been explored in medical and computer science research for some time now. Much has been written about its potential …
Guide to Lung Function Tests: Types, Procedures, and Indications for Diagnosis, Monitoring, and Assessment of Respiratory Conditions
What are lung function tests? Lung function tests are medical tests that are used to assess whether the lungs are functioning properly. These tests measure a range of values …
The Science is In: How Social Support Can Shield You from Depression in Your Darkest Times!
A study was published by a team of researchers at the University of Michigan exploring the impact of adequate social support in decreasing the risk of developing depression in …
FDA Gives Green Light to Lecanemab, Offering New Hope for Alzheimer’s Patients
In January 2023, the U.S. Food and Drug Administration approved a new drug called Lecanemab for treating Alzheimer’s disease. Lecanemab is the second of the disease-modifying drugs approved for …
A New Perspective on Rheumatoid Arthritis: Could Oral Bacteria be a Causative Factor?
A study was published in the Science Translational Medicine journal studying the role of oral bacteria in the pathogenesis of rheumatoid arthritis. The study was performed by analyzing patient …
Muscle Mass Enhancement: Yamanaka Factors Accelerate Muscle Regeneration in Mice
Scientists from the Salk Institute published a study in Nature Communications recently that focused on enhancing muscle regeneration in mice using various molecular compounds. Loss of muscle mass occurs …